Initiating Highly Active Antiretroviral Therapy with Newer Protease Inhibitors Is Associated with Better Survival Compared to First-Generation Protease Inhibitors or Nevirapine
Author:
Affiliation:
1. Department of Medicine, University of Washington, Seattle, Washington.
Publisher
Mary Ann Liebert Inc
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Link
http://www.liebertpub.com/doi/pdf/10.1089/apc.2007.0020
Reference37 articles.
1. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
2. Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients
3. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses
4. Initial Treatment of HIV Infection: Randomized Trials with Clinical End Points Are Still Needed
5. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Primary, secondary and compensated male biochemical hypogonadism in people living with HIV (PLWH): relevance of sex hormone-binding globulin (SHBG) measurement and comparison between liquid chromatography-tandem mass spectrometry (LC-MS/MS) and chemiluminescent immunoassay for sex steroids assay;The Aging Male;2022-03-23
2. Survie des patients vivant avec le VIH-1 sous thérapie antirétrovirale au Maroc;Revue d'Épidémiologie et de Santé Publique;2018-09
3. Hepatitis B, hepatitis C, and mortality among HIV-positive individuals;AIDS;2017-11-28
4. Influence of Treatment Complexity on Adherence and Incidence of Blips in HIV/HCV Coinfected Patients;Journal of Managed Care & Specialty Pharmacy;2015-02
5. Antiretroviral drugs: Critical issues and recent advances;Indian Journal of Pharmacology;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3